Cytori Therapeutics Inc (CYTX) 1.33 $CYTX Cytori

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cytori Therapeutics Inc (CYTX) 1.33 $CYTX

Cytori Therapeutics' (CYTX) CEO Marc Hedrick on Q4 2014 Results -- Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Mar 13, 6:19PM CDT

CYTX: 1.33 (+0.13)

Cytori Therapeutics (CYTX) Stock: Weak On High Volume Today
at The Street - Fri Mar 13, 9:03AM CDT
Trade-Ideas LLC identified Cytori Therapeutics (CYTX) as a weak on high relative volume candidate
CYTX: 1.33 (+0.13)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Mar 13, 8:14AM CDT

HIBB: 48.77 (-2.06), WLL: 37.82 (-2.18), ANN: 41.41 (+0.96), AXN: 1.73 (+0.07), CBPX: 19.05 (+0.10), CTIC: 1.98 (+0.01), FXCM: 2.40 (-0.18), ARO: 2.93 (-0.13), GENE: 4.47 (-0.24), ONVO: 4.42 (-0.28), CYTX: 1.33 (+0.13), LOCO: 26.73 (-0.37), GALE: 1.38 (-0.04), ULTA: 150.12 (+0.02), CUR: 2.39 (-0.17)

Cytori Therapeutics EPS in-line, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Mar 12, 3:57PM CDT

CYTX: 1.33 (+0.13)

Cytori Reports Fourth Quarter and Full Year 2014 Business and Financial Results
Business Wire - Thu Mar 12, 3:30PM CDT
Cytori Therapeutics (NASDAQ: CYTX) today announced its fourth quarter and year end 2014 business and financial results.
CYTX: 1.33 (+0.13)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Mar 11, 11:47AM CDT

BAK: 6.87 (+0.13), MELA: 3.22 (+0.18), ZGNX: 1.31 (+0.01), EOX: 0.90 (-0.11), MRD: 16.25 (-1.29), ULTR: 1.18 (+0.02), BLT: 13.30 (-0.11), RESN: 9.16 (-0.84), GBSN: 2.35 (-0.01), CYTX: 1.33 (+0.13), WRES: 1.00 (-0.05), MTL: 1.04 (-0.50), VRA: 15.52 (+0.27), CTP: 6.91 (-0.34), ENRJ: 1.52 (+0.02), CORT: 4.18 (+0.18), CBMG: 40.20 (+0.64), SPP: 1.66 (-0.34), CAPN: 6.06 (-0.30), SZYM: 2.78 (-0.25)

Most active Nasdaq-traded stocks
AP - Tue Mar 10, 12:41PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
MU: 28.28 (-0.44), GERN: 4.14 (-0.20), FB: 77.57 (-0.48), CYTX: 1.33 (+0.13), MSFT: 41.33 (-0.05), INTC: 30.79 (-0.14), GEVO: 0.23 (-0.02), AAPL: 124.16 (+0.57), CSCO: 28.20 (+0.26)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Mon Mar 09, 8:12AM CDT

ACRX: 3.96 (-0.09), WLL: 37.82 (-2.18), RXII: 1.20 (+0.05), RMGN: 1.83 (+0.06), LBIO: 13.55 (+0.43), NBG: 1.27 (+0.04), CTIC: 1.98 (+0.01), RTI: 36.98 (-0.81), GLPI: 36.06 (+0.05), PNK: 34.79 (+0.40), CYTX: 1.33 (+0.13), AVEO: 1.28 (-0.12), MAC: 95.30 (+0.91)

Next Week In Biotech: Kythera Ad Comm, Roth Conference, Zogenix Earnings
SA Editor Mike Taylor - at Seeking Alpha - Fri Mar 06, 8:00AM CST
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
BDSI: 14.85 (+0.08), OMED: 27.64 (+0.45), BIOA: 8.99 (+0.07), SUPN: 11.55 (-0.22), CTIC: 1.98 (+0.01), ALXA: 1.96 (+0.01), DSCI: 8.07 (+0.12), ANTH: 4.45 (-1.03), CYTX: 1.33 (+0.13), KYTH: 50.18 (-0.47), ANAC: 56.90 (+1.24), ATHX: 2.94 (+0.12), CRMD: 8.02 (-0.38), ACRX: 3.96 (-0.09), TROV: 6.77 (+0.52), ZGNX: 1.31 (+0.01), PETX: 18.34 (-0.44), RPRX: 9.17 (-0.09), IMUC: 0.56 (-0.01), PGNX: 6.32 (-0.77), SNTA: 2.31 (-0.01), BLCM: 24.67 (+1.84), TXMD: 5.53 (-0.22), OGXI: 2.29 (-0.09), AST: 8.30 (+0.55), PLX: 1.78 (+0.03), ATRS: 2.68 (+0.03)

Cytori preliminary Q4 product revenues $2.5M; 2015 revenue growth 0 - 60%
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 9:48AM CST

CYTX: 1.33 (+0.13)

Cytori Therapeutics (CYTX) Jumps: Stock Moves 7.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 8:25AM CST
Cytori Therapeutics (CYTX) was a big mover last session, with shares rising over 7% on the day.
CYTX: 1.33 (+0.13), AFFX: 12.86 (+0.25)

Cytori to Provide Corporate Update at Cowen and Company 35th Annual Health Care Conference
Business Wire - Tue Mar 03, 7:00AM CST
Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that Dr. Marc H. Hedrick, President and CEO of Cytori Therapeutics, will present at the 35th Annual Cowen and Company Health Care Conference in Boston, March 2-5, 2015. Cytori's presentation is scheduled to begin March 4th at 8:40 AM Eastern Time, in Salon H, on the 4th floor of the Boston Marriott Copley Place. A breakout session will follow at 9:20 AM, in Salon I, on the 4th floor.
CYTX: 1.33 (+0.13)

Nasdaq stocks posting largest volume increases
AP - Fri Feb 27, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
ATOS: 1.90 (-0.03), UNXL: 6.90 (-0.19), CYCC: 1.00 (-0.05), CYTX: 1.33 (+0.13), TBIO: 1.46 (-0.04), LKQ: 24.54 (+0.12), QBAK: 1.46 (-0.04), ESSX: 0.75 (unch), BWFG: 18.70 (-0.10), ONFC: 19.75 (+0.02), CYBX: 67.02 (+1.76)

Cytori zooms up on trial expansion
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 12:29PM CST

CYTX: 1.33 (+0.13)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Use Hits 93% in Health Systems' Digital Shift

Updated Category News Views 33

Healthcare's AI Surge: Jumping the Adoption Hurdle The digital health landscape isn't just humming along—it's hitting high gear. AI, once the shiny toy in innovation's toolkit, is now a fixture in 93.2% of healthcare systems according to CHIME's latest findings. For anyone keeping score, that's a hefty leap and paints a picture where AI isn't just in the game, it's...

Continue Reading
Dana Concludes Tender Offers for Senior Notes

Updated Category News Views 72

An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...

Continue Reading
Later's NYC Summit Reinvents Social Commerce Game Plan

Updated Category News Views 120

Creators and Corporates Collide Imagine this: an NYC stage not adorned with Broadway's finest, but with digital maestros steering a new age in social commerce. That's what Later is betting on with their Creator Live summit, debuting in the bustling heart of New York City. We're talking about influencers not just as Instagram stars, but as key players in a $480 billion...

Continue Reading
Koppers Faces SEC Scrutiny After Earnings Miss

Updated Category News Views 124

Koppers' Third-Quarter Blues: Missing the Mark Koppers Holdings Inc. (NYSE: KOP) took a hard hit this quarter, missing Wall Street's earnings expectations by a mile. The adjusted earnings per share came in at just $0.77, while the suits down on Wall Street were expecting something closer to $1.34 to $1.37. Now, if you’re holding KOP in your portfolio, you're probably...

Continue Reading
National Police Assoc. Urges House to Pass PTSD Act

Updated Category News Views 101

An Urgent Call for Action on PTSD Support Alright folks, this ain't your typical investment rundown, but it's got stakes just the same. The National Police Association is sounding the horn for the House to pass the Fighting Post-Traumatic Stress Disorder Act of 2025 (S. 825). Now, if you've been around the block, you know legislation can play out like a market...

Continue Reading
CR&R Workers Join Teamsters, Fight for Fair Conditions

Updated Category News Views 74

Waste Workers Push Back Against Corporate Pressure The Southern California sun isn't the only thing heating up these days; the waste workers at CR&R Environmental Services have cranked up the heat by voting to join Teamsters Local 396. It's like Groundhog Day in the world of labor rights—same story, different locale, workers banding together for a fair shot. A Stand...

Continue Reading
SOCSA: The Future of Safety in Confined Spaces?

Updated Category News Views 68

Autonomous Tech Meets Safety Regulations Some days innovation hits like a ton of bricks, and here we go again—this time with a gizmo aiming to shake up the safety game in confined spaces. Enter the SOCSA, the Self Operating Confined Space Attendant, designed by a seasoned agriculture worker who's had a ringside seat to enough OSHA rule breaches to fill a book. But ain't...

Continue Reading
Accuray Finishes Key Deal, Resetting Financial Trajectory

Updated Category News Views 112

Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...

Continue Reading
Citigroup, Scotia Aid TSTT in $500M Note Offering

Updated Category News Views 49

Kicking off with a banger that’s got financial water coolers buzzing, Greenberg Traurig just pulled a rabbit out of the hat helping Citigroup and Scotia Capital orchestrate a chunky near $500 million dual-currency notes deal for Telecommunications Services of Trinidad and Tobago Limited (TSTT). Now, this isn’t your run-of-the-mill market maneuver. We're seeing a...

Continue Reading
Agiloft Navigates New Growth Phase with Key Leadership

Updated Category News Views 142

Leadership Shifts Steer Agiloft's EMEA Journey Agiloft's latest shake-ups in leadership signal a determined charge through EMEA's bustling markets. Nick Bowles, a seasoned veteran in enterprise software, steps into the limelight as Senior Vice President, while Jim Leason shifts gears into a customer-focused advisory role. These aren’t just routine hiring...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Innovative Glaucoma Research with 2025 Grants Announcement

Updated Category News Views 283

2025 Shaffer Grants Foster Groundbreaking Glaucoma Research In an exciting development in the field of ophthalmology, the Glaucoma Research Foundation (GRF) has revealed its nine recipients of the prestigious 2025 Shaffer Research Grants, totaling $55,000. These grants are designed to support innovative research aimed at understanding and potentially transforming...

Continue Reading
Beyond Air's Participation in Upcoming Investment Conference

Updated Category News Views 141

Beyond Air to Engage at H.C. Wainwright Conference Beyond Air, Inc. (NASDAQ: XAIR), a pioneering biopharmaceutical company known for its innovative approach to medical devices, recently declared its commitment to participate in the H.C. Wainwright 27th Annual Global Investment Conference. Steve Lisi, the Chairman and Chief Executive Officer, will represent the company at...

Continue Reading
Investors Urged to Act on Sable Offshore Corp. Securities Case

Updated Category News Views 150

Investors Now Have an Important Opportunity with Sable Offshore Corp. In light of recent developments, investor awareness regarding Sable Offshore Corp. (NYSE: SOC) has become crucial. Allegations of securities fraud have emerged, prompting a thorough investigation led by the DJS Law Group. This investigation centers around potential violations of securities laws, raising...

Continue Reading
Coeur Mining Prepares for Q4 and Full-Year 2024 Earnings Results

Updated Category News Views 131

Coeur Mining Earnings Report Announcement Coeur Mining, Inc. (NYSE: CDE) is gearing up to release its operational and financial outcomes for the fourth quarter and the full year of 2024. This report is poised to be made public following the close of the New York Stock Exchange on a specified date. Following the announcement, Coeur will host a conference call to discuss...

Continue Reading
Exploring Option Care Health's Robust Financial Victory for 2024

Updated Category News Views 85

Financial Overview of Option Care Health Option Care Health, Inc. (NASDAQ: OPCH), recognized as the largest independent provider of home and alternate site infusion services, recently shared its financial results for the fourth quarter and the entirety of 2024. Their performance reflects strategic execution and strong market demand despite a challenging environment....

Continue Reading